Medicine shortages in Taiwan
Live register of drug shortage notices in Taiwan, aggregated daily from official regulator publications and linked back to every source.
Regulators list each strength and pack separately, so one medicine can carry several notices — compare official per-medicine tallies against “Medicines affected”. How we count
Latest shortage notices in Taiwan
| Medicine | Status | Severity | Since | Source |
|---|---|---|---|---|
| Amlodipine Besylate; Valsartan | active | medium | 21 Oct 2026 | TFDA |
| Epirubicin | active | medium | 15 Oct 2026 | TFDA |
| Codeine Phosphate; Terpin Hydrate | active | medium | 7 Oct 2026 | TFDA |
| Amikacin | active | medium | 5 Oct 2026 | TFDA |
| Heparin Sodium | active | medium | 18 Sept 2026 |
Official sources for Taiwan
- TFDA — Drug Supply Information Platform (Taiwan) (TFDA) — official register · last checked 1 Nov 2026
Frequently asked questions
How many medicines are in shortage in Taiwan?
Taiwan currently has 203 active medicine shortage notices and 1 anticipated. Figures update daily from official regulator publications.
Who reports medicine shortages in Taiwan?
Official shortage notices for Taiwan are published by TFDA — Drug Supply Information Platform (Taiwan) (TFDA). Mederti checks this source daily and links every notice back to the original publication.
How current is this Taiwan shortage data?
Mederti scrapes Taiwan's official shortage register daily. Each notice carries the regulator's own dates; the list on this page reflects the most recent successful update.
Track Taiwan shortages that matter to you
Watchlists, email alerts, alternatives and cross-country comparison — free for individual pharmacists and clinicians.
Create a free accountData is aggregated from official sources and provided for information only. Mederti is not affiliated with or endorsed by any regulator. Verify with TFDA before clinical or procurement decisions.